Serum CS/DS, IGF-1, and IGFBP-3 as Biomarkers of Cartilage Remodeling in Juvenile Idiopathic Arthritis: Diagnostic and Therapeutic Implications
2024

Biomarkers of Cartilage Remodeling in Juvenile Idiopathic Arthritis

Sample size: 55 publication 10 minutes Evidence: high

Author Information

Author(s): Winsz-Szczotka Katarzyna, Kuźnik-Trocha Kornelia, Koźma Ewa M., Żegleń Bogusław, Gruenpeter Anna, Wisowski Grzegorz, Komosińska-Vassev Katarzyna, Olczyk Krystyna, Scuruchi Michele

Primary Institution: Medical University of Silesia

Hypothesis

Can serum CS/DS, IGF-1, and IGFBP-3 serve as biomarkers for early diagnosis and treatment efficacy in juvenile idiopathic arthritis?

Conclusion

Serum levels of CS/DS, IGF-1, and IGFBP-3 are significantly altered in juvenile idiopathic arthritis and can be useful for diagnosis and monitoring treatment.

Supporting Evidence

  • CS/DS levels were significantly lower in untreated JIA patients compared to controls.
  • Therapy led to a significant increase in CS/DS levels but did not normalize them.
  • IGF-1 and IGFBP-3 levels were also significantly lower in untreated JIA patients.
  • CS/DS demonstrated the highest diagnostic power for JIA among all tested markers.
  • Significant correlations were found between CS/DS and IGF-1, IGFBP-3, and CRP levels.

Takeaway

Doctors can check certain substances in the blood to see if kids with joint pain have a condition called juvenile idiopathic arthritis and how well they are responding to treatment.

Methodology

This case-control study measured serum levels of CS/DS, IGF-1, and IGFBP-3 in JIA patients before and after treatment using ELISA methods.

Potential Biases

Potential bias due to the small number of male patients and the specific population studied.

Limitations

The study had a small sample size and a higher prevalence of females among participants.

Participant Demographics

Fifty-five Polish Caucasian children (41 girls, 14 boys) aged 7.31 ± 4.86 years.

Statistical Information

P-Value

p = 0.00004 for CS/DS, p = 0.0044 for IGF-1, p = 0.0002 for IGFBP-3

Confidence Interval

6.25–9.66 for untreated JIA CS/DS levels

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/biom14121526

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication